BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24354684)

  • 1. Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.
    Jimenez-Zepeda VH; Reece DE; Trudel S; Franke N; Winter A; Chen C; Tiedemann R; Kukreti V
    Leuk Lymphoma; 2014 Oct; 55(10):2284-9. PubMed ID: 24354684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The therapeutic effect and prognostic value of oligoclonal bands after autologous stem cell transplant in patients with multiple myeloma].
    Shi QL; Xu Y; Wang J; Jin YY; Zhang R; Li JY; Chen LJ
    Zhonghua Yi Xue Za Zhi; 2024 Feb; 104(7):514-520. PubMed ID: 38317363
    [No Abstract]   [Full Text] [Related]  

  • 3. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
    Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
    Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant.
    Jimenez-Zepeda VH; Reece DE; Trudel S; Chen C; Franke N; Winter A; Tiedemann R; Kukreti V
    Leuk Lymphoma; 2015; 56(9):2668-73. PubMed ID: 25573201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal bands and immunoglobulin isotype switch during monitoring of patients with multiple myeloma and autologous hematopoietic cell transplantation: a 16-year experience.
    Alejandre ME; Madalena LB; Pavlovsky MA; Facio ML; Corrado C; Milone G; Bresciani PD; Fraind SA; Pavlovsky S; Pizzolato MA
    Clin Chem Lab Med; 2010 May; 48(5):727-31. PubMed ID: 20450334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. oligoclonal bands in patients with multiple myeloma: its emergence per se could not be translated to improved survival.
    Fujisawa M; Seike K; Fukumoto K; Suehara Y; Fukaya M; Sugihara H; Takeuchi M; Matsue K
    Cancer Sci; 2014 Nov; 105(11):1442-6. PubMed ID: 25182124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential humoral responses against heat-shock proteins after autologous stem cell transplantation in multiple myeloma.
    Tovar N; Fernández de Larrea C; Pedrosa F; Aróstegui JI; Cibeira MT; Rosiñol L; Elena M; Filella X; Yagüe J; Bladé J
    Ann Hematol; 2014 Jan; 93(1):107-11. PubMed ID: 24218189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Clinical Significance of Oligoclonal Bands in Patient with Multiple Myeloma].
    Liu JH; Fan HS; Yan WQ; Xu JY; Li LN; Xu Y; Yi SH; Zou DH; Qiu LG; An G
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1453-1463. PubMed ID: 36208249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry.
    Huang TC; Huang SY; Yao M; Lin CY; Hwang WL; Gau JP; Tan TD; Wang PN; Liu YC; Lin SC; Kao RH; Pei SN; Yu MS; Lin HY; Su YC; Chen CC; Li SS; Wu YY
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):471-480. PubMed ID: 30119948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
    Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum free light chains and oligoclonal bands in patients with multiple myeloma and autologous stem cell transplantation.
    Alejandre ME; Pavlovsky MA; Remaggi G; Corrado C; Fernandez I; Milone G; Pavlovsky A; Madalena L; Pandolfo M; Facio ML; Bresciani P; Pavlovsky S; Pizzolato MA
    Clin Chem Lab Med; 2012 Apr; 50(6):1093-7. PubMed ID: 22706252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients.
    Krejci M; Buchler T; Hajek R; Svobodnik A; Krivanova A; Pour L; Adam Z; Mayer J; Vorlicek J
    Bone Marrow Transplant; 2005 Jan; 35(2):159-64. PubMed ID: 15543200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A serum microRNA signature associated with complete remission and progression after autologous stem-cell transplantation in patients with multiple myeloma.
    Navarro A; Díaz T; Tovar N; Pedrosa F; Tejero R; Cibeira MT; Magnano L; Rosiñol L; Monzó M; Bladé J; Fernández de Larrea C
    Oncotarget; 2015 Jan; 6(3):1874-83. PubMed ID: 25593199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Retrospective analysis on therapeutic effect of autologous hematopoietic stem cell transplantation in multiple myeloma patients].
    Wang J; Fu CC; Wu DP; Sun AN; Xue SL; Xin X; Hu XH; Wang Y; Qiu HY; Jin ZM; Miao M; Tang XW; Han Y; Ma X; He GS; Chang WR; Chen SN
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):114-8. PubMed ID: 23648347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history and prognostic impact of oligoclonal humoral response in patients with multiple myeloma after autologous stem cell transplantation: long-term results from a single institution.
    Tovar N; de Larrea CF; Aróstegui JI; Cibeira MT; Rosiñol L; Rovira M; Elena M; Filella X; Yagüe J; Bladé J
    Haematologica; 2013 Jul; 98(7):1142-6. PubMed ID: 23645688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous stem cell transplantation for multiple myeloma: Long-term results.
    Kumar L; Boya RR; Pai R; Harish P; Mookerjee A; Sainath B; Patekar MB; Sahoo RK; Malik PS; Sharma OD; Gupta R
    Natl Med J India; 2016; 29(4):192-199. PubMed ID: 28050994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.
    Jimenez-Zepeda VH; Mikhael J; Winter A; Franke N; Masih-Khan E; Trudel S; Chen C; Kukreti V; Reece DE
    Biol Blood Marrow Transplant; 2012 May; 18(5):773-9. PubMed ID: 22062804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of the appearance of abnormal protein band in patients with multiple myeloma.
    Jo JC; Yoon DH; Kim S; Lee K; Kang EH; Jang S; Park CJ; Chi HS; Huh J; Park CS; Suh C
    Ann Hematol; 2014 Mar; 93(3):463-9. PubMed ID: 23999647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes after autologous stem cell transplantation between myeloma patients with skeletal and soft tissue plasmacytoma.
    Shin HJ; Kim K; Lee JW; Song MK; Lee JJ; Lee HS; Lee WS; Kim SJ; Chung JS
    Eur J Haematol; 2014 Nov; 93(5):414-21. PubMed ID: 24813053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.